{
    "2021-07-02": [
        [
            {
                "time": "",
                "original_text": "凯莱英(002821.SZ)参股子公司拟引入产业资本增资扩股以充实资本实力",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "参股子公司",
                        "产业资本",
                        "增资扩股",
                        "资本实力"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "小分子“王者”凯莱英再冲港股，重仓大分子业务，要跟药明生物抢地盘",
                "features": {
                    "keywords": [
                        "凯莱英",
                        "港股",
                        "小分子",
                        "大分子业务",
                        "药明生物"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "",
                "original_text": "药明康德领衔，这个医药细分会成为十年十倍的机会么？",
                "features": {
                    "keywords": [
                        "药明康德",
                        "医药细分",
                        "十年十倍",
                        "机会"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}